JP2018115098A - Surface treated zinc oxide powder and usage thereof - Google Patents
Surface treated zinc oxide powder and usage thereof Download PDFInfo
- Publication number
- JP2018115098A JP2018115098A JP2017008420A JP2017008420A JP2018115098A JP 2018115098 A JP2018115098 A JP 2018115098A JP 2017008420 A JP2017008420 A JP 2017008420A JP 2017008420 A JP2017008420 A JP 2017008420A JP 2018115098 A JP2018115098 A JP 2018115098A
- Authority
- JP
- Japan
- Prior art keywords
- zinc oxide
- dispersion
- oxide powder
- powder
- treated zinc
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 title claims abstract description 96
- 239000006185 dispersion Substances 0.000 claims abstract description 61
- -1 no aluminum element Chemical compound 0.000 claims abstract description 47
- 239000002537 cosmetic Substances 0.000 claims abstract description 39
- 239000002245 particle Substances 0.000 claims abstract description 33
- 239000000843 powder Substances 0.000 claims abstract description 32
- 239000003960 organic solvent Substances 0.000 claims abstract description 21
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims abstract description 12
- 238000004566 IR spectroscopy Methods 0.000 claims abstract description 7
- 239000011164 primary particle Substances 0.000 claims description 13
- 238000009826 distribution Methods 0.000 claims description 10
- 229920002545 silicone oil Polymers 0.000 claims description 6
- 229940071124 cocoyl glutamate Drugs 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 abstract description 9
- 235000001014 amino acid Nutrition 0.000 description 34
- 229940024606 amino acid Drugs 0.000 description 34
- 238000000034 method Methods 0.000 description 28
- 235000014692 zinc oxide Nutrition 0.000 description 23
- 239000011787 zinc oxide Substances 0.000 description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 22
- 235000014113 dietary fatty acids Nutrition 0.000 description 19
- 239000000194 fatty acid Substances 0.000 description 19
- 229930195729 fatty acid Natural products 0.000 description 19
- 239000003921 oil Substances 0.000 description 16
- 238000004381 surface treatment Methods 0.000 description 16
- 235000019198 oils Nutrition 0.000 description 15
- 150000001413 amino acids Chemical class 0.000 description 11
- 229920001296 polysiloxane Polymers 0.000 description 11
- 239000002253 acid Substances 0.000 description 10
- 238000001035 drying Methods 0.000 description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- 239000004166 Lanolin Substances 0.000 description 9
- 230000032683 aging Effects 0.000 description 9
- 229940039717 lanolin Drugs 0.000 description 9
- 235000019388 lanolin Nutrition 0.000 description 9
- 229920000642 polymer Polymers 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 8
- 239000007788 liquid Substances 0.000 description 8
- 239000002994 raw material Substances 0.000 description 8
- 239000002612 dispersion medium Substances 0.000 description 7
- 150000004665 fatty acids Chemical group 0.000 description 7
- 229910052751 metal Inorganic materials 0.000 description 7
- 239000002184 metal Substances 0.000 description 7
- 230000000704 physical effect Effects 0.000 description 7
- 239000002002 slurry Substances 0.000 description 7
- 239000010419 fine particle Substances 0.000 description 6
- 235000011187 glycerol Nutrition 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 238000002156 mixing Methods 0.000 description 6
- 229920000570 polyether Polymers 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 5
- 239000004721 Polyphenylene oxide Substances 0.000 description 5
- 239000003242 anti bacterial agent Substances 0.000 description 5
- 229920002678 cellulose Polymers 0.000 description 5
- 239000001913 cellulose Substances 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 4
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 4
- 229920002472 Starch Polymers 0.000 description 4
- 235000015278 beef Nutrition 0.000 description 4
- 239000004359 castor oil Substances 0.000 description 4
- 235000019438 castor oil Nutrition 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 239000003240 coconut oil Substances 0.000 description 4
- 239000003085 diluting agent Substances 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 235000013922 glutamic acid Nutrition 0.000 description 4
- 239000004220 glutamic acid Substances 0.000 description 4
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 4
- 150000002739 metals Chemical class 0.000 description 4
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 4
- 239000008107 starch Substances 0.000 description 4
- 235000019698 starch Nutrition 0.000 description 4
- 239000001993 wax Substances 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 238000010306 acid treatment Methods 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 150000005215 alkyl ethers Chemical class 0.000 description 3
- 239000011324 bead Substances 0.000 description 3
- 235000019864 coconut oil Nutrition 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- LPUQAYUQRXPFSQ-DFWYDOINSA-M monosodium L-glutamate Chemical compound [Na+].[O-]C(=O)[C@@H](N)CCC(O)=O LPUQAYUQRXPFSQ-DFWYDOINSA-M 0.000 description 3
- 239000002736 nonionic surfactant Substances 0.000 description 3
- 239000003973 paint Substances 0.000 description 3
- 229940079781 sodium cocoyl glutamate Drugs 0.000 description 3
- 150000005846 sugar alcohols Polymers 0.000 description 3
- 239000012756 surface treatment agent Substances 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 210000004243 sweat Anatomy 0.000 description 3
- 239000003760 tallow Substances 0.000 description 3
- 239000002562 thickening agent Substances 0.000 description 3
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 2
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- 229910018072 Al 2 O 3 Inorganic materials 0.000 description 2
- 235000017788 Cydonia oblonga Nutrition 0.000 description 2
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 2
- 229920000161 Locust bean gum Polymers 0.000 description 2
- 235000019482 Palm oil Nutrition 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 2
- 108010077895 Sarcosine Proteins 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- MCMNRKCIXSYSNV-UHFFFAOYSA-N Zirconium dioxide Chemical compound O=[Zr]=O MCMNRKCIXSYSNV-UHFFFAOYSA-N 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- 150000003863 ammonium salts Chemical class 0.000 description 2
- 125000000129 anionic group Chemical group 0.000 description 2
- 230000002421 anti-septic effect Effects 0.000 description 2
- 235000003704 aspartic acid Nutrition 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical compound NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 description 2
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 2
- 239000010495 camellia oil Substances 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 125000002091 cationic group Chemical group 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 239000002270 dispersing agent Substances 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 229920000591 gum Polymers 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 239000000976 ink Substances 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 235000010420 locust bean gum Nutrition 0.000 description 2
- 239000000711 locust bean gum Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000002105 nanoparticle Substances 0.000 description 2
- 239000002540 palm oil Substances 0.000 description 2
- 229960005323 phenoxyethanol Drugs 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 229920000058 polyacrylate Polymers 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- XOJVVFBFDXDTEG-UHFFFAOYSA-N pristane Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 description 2
- 229960002429 proline Drugs 0.000 description 2
- 239000005871 repellent Substances 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 229940043230 sarcosine Drugs 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- 235000010199 sorbic acid Nutrition 0.000 description 2
- 239000004334 sorbic acid Substances 0.000 description 2
- 229940075582 sorbic acid Drugs 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- AVBJHQDHVYGQLS-AWEZNQCLSA-N (2s)-2-(dodecanoylamino)pentanedioic acid Chemical compound CCCCCCCCCCCC(=O)N[C@H](C(O)=O)CCC(O)=O AVBJHQDHVYGQLS-AWEZNQCLSA-N 0.000 description 1
- MTJZWYHTZFVEGI-INIZCTEOSA-N (2s)-2-(tetradecanoylamino)pentanedioic acid Chemical compound CCCCCCCCCCCCCC(=O)N[C@H](C(O)=O)CCC(O)=O MTJZWYHTZFVEGI-INIZCTEOSA-N 0.000 description 1
- RUHCWQAFCGVQJX-RVWHZBQESA-N (3s,8s,9s,10r,13r,14s,17r)-3-hydroxy-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-1-one Chemical compound C1C=C2C[C@H](O)CC(=O)[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 RUHCWQAFCGVQJX-RVWHZBQESA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical group NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- NGOZDSMNMIRDFP-UHFFFAOYSA-N 2-[methyl(tetradecanoyl)amino]acetic acid Chemical compound CCCCCCCCCCCCCC(=O)N(C)CC(O)=O NGOZDSMNMIRDFP-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- DCVMAYAWOPBYKB-UHFFFAOYSA-N 3-[methyl(tetradecanoyl)amino]propanoic acid Chemical compound CCCCCCCCCCCCCC(=O)N(C)CCC(O)=O DCVMAYAWOPBYKB-UHFFFAOYSA-N 0.000 description 1
- SATHPVQTSSUFFW-UHFFFAOYSA-N 4-[6-[(3,5-dihydroxy-4-methoxyoxan-2-yl)oxymethyl]-3,5-dihydroxy-4-methoxyoxan-2-yl]oxy-2-(hydroxymethyl)-6-methyloxane-3,5-diol Chemical compound OC1C(OC)C(O)COC1OCC1C(O)C(OC)C(O)C(OC2C(C(CO)OC(C)C2O)O)O1 SATHPVQTSSUFFW-UHFFFAOYSA-N 0.000 description 1
- CFKMVGJGLGKFKI-UHFFFAOYSA-N 4-chloro-m-cresol Chemical compound CC1=CC(O)=CC=C1Cl CFKMVGJGLGKFKI-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-UHFFFAOYSA-N 5-oxoproline Chemical compound OC(=O)C1CCC(=O)N1 ODHCTXKNWHHXJC-UHFFFAOYSA-N 0.000 description 1
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 1
- XZOYHFBNQHPJRQ-UHFFFAOYSA-N 7-methyloctanoic acid Chemical compound CC(C)CCCCCC(O)=O XZOYHFBNQHPJRQ-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 239000001904 Arabinogalactan Substances 0.000 description 1
- 229920000189 Arabinogalactan Polymers 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 235000012137 Atriplex confertifolia Nutrition 0.000 description 1
- 244000266618 Atriplex confertifolia Species 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 241000195940 Bryophyta Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 108010076119 Caseins Proteins 0.000 description 1
- 102000011632 Caseins Human genes 0.000 description 1
- 235000003301 Ceiba pentandra Nutrition 0.000 description 1
- 244000146553 Ceiba pentandra Species 0.000 description 1
- 241000283153 Cetacea Species 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical group CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- CMBYOWLFQAFZCP-UHFFFAOYSA-N Hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- BACYUWVYYTXETD-UHFFFAOYSA-N N-Lauroylsarcosine Chemical compound CCCCCCCCCCCC(=O)N(C)CC(O)=O BACYUWVYYTXETD-UHFFFAOYSA-N 0.000 description 1
- ATFFFUXLAJBBDE-FQEVSTJZSA-N N-Stearoyl glutamic acid Chemical compound CCCCCCCCCCCCCCCCCC(=O)N[C@H](C(O)=O)CCC(O)=O ATFFFUXLAJBBDE-FQEVSTJZSA-N 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- OQILCOQZDHPEAZ-UHFFFAOYSA-N Palmitinsaeure-octylester Natural products CCCCCCCCCCCCCCCC(=O)OCCCCCCCC OQILCOQZDHPEAZ-UHFFFAOYSA-N 0.000 description 1
- 235000010678 Paulownia tomentosa Nutrition 0.000 description 1
- 240000002834 Paulownia tomentosa Species 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- YNPNZTXNASCQKK-UHFFFAOYSA-N Phenanthrene Natural products C1=CC=C2C3=CC=CC=C3C=CC2=C1 YNPNZTXNASCQKK-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920002873 Polyethylenimine Polymers 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- HDSBZMRLPLPFLQ-UHFFFAOYSA-N Propylene glycol alginate Chemical compound OC1C(O)C(OC)OC(C(O)=O)C1OC1C(O)C(O)C(C)C(C(=O)OCC(C)O)O1 HDSBZMRLPLPFLQ-UHFFFAOYSA-N 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 235000019774 Rice Bran oil Nutrition 0.000 description 1
- 235000004443 Ricinus communis Nutrition 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 241001558929 Sclerotium <basidiomycota> Species 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 241000270666 Testudines Species 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 235000006732 Torreya nucifera Nutrition 0.000 description 1
- 244000111306 Torreya nucifera Species 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical group OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical group CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 230000006750 UV protection Effects 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 229910007541 Zn O Inorganic materials 0.000 description 1
- DGEZNRSVGBDHLK-UHFFFAOYSA-N [1,10]phenanthroline Chemical compound C1=CN=C2C3=NC=CC=C3C=CC2=C1 DGEZNRSVGBDHLK-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 125000005250 alkyl acrylate group Chemical group 0.000 description 1
- 150000003973 alkyl amines Chemical class 0.000 description 1
- 125000003282 alkyl amino group Chemical group 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 229940009868 aluminum magnesium silicate Drugs 0.000 description 1
- LPXDKRZWFWKMST-UHFFFAOYSA-N aluminum;iron Chemical compound [Al+3].[Fe].[Fe].[Fe] LPXDKRZWFWKMST-UHFFFAOYSA-N 0.000 description 1
- WMGSQTMJHBYJMQ-UHFFFAOYSA-N aluminum;magnesium;silicate Chemical compound [Mg+2].[Al+3].[O-][Si]([O-])([O-])[O-] WMGSQTMJHBYJMQ-UHFFFAOYSA-N 0.000 description 1
- ANBBXQWFNXMHLD-UHFFFAOYSA-N aluminum;sodium;oxygen(2-) Chemical compound [O-2].[O-2].[Na+].[Al+3] ANBBXQWFNXMHLD-UHFFFAOYSA-N 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 229960002684 aminocaproic acid Drugs 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 235000019312 arabinogalactan Nutrition 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 239000012179 bayberry wax Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229960004365 benzoic acid Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 229940000635 beta-alanine Drugs 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 229910052792 caesium Inorganic materials 0.000 description 1
- TVFDJXOCXUVLDH-UHFFFAOYSA-N caesium atom Chemical compound [Cs] TVFDJXOCXUVLDH-UHFFFAOYSA-N 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- VNSBYDPZHCQWNB-UHFFFAOYSA-N calcium;aluminum;dioxido(oxo)silane;sodium;hydrate Chemical compound O.[Na].[Al].[Ca+2].[O-][Si]([O-])=O VNSBYDPZHCQWNB-UHFFFAOYSA-N 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 229920006317 cationic polymer Polymers 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000008199 coating composition Substances 0.000 description 1
- 239000000571 coke Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 229920006037 cross link polymer Polymers 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 description 1
- 229910003460 diamond Inorganic materials 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical group OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- 125000001664 diethylamino group Chemical group [H]C([H])([H])C([H])([H])N(*)C([H])([H])C([H])([H])[H] 0.000 description 1
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000003670 easy-to-clean Effects 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000010696 ester oil Substances 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 125000003916 ethylene diamine group Chemical group 0.000 description 1
- GJQLBGWSDGMZKM-UHFFFAOYSA-N ethylhexyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(CC)CCCCC GJQLBGWSDGMZKM-UHFFFAOYSA-N 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- KWLMIXQRALPRBC-UHFFFAOYSA-L hectorite Chemical compound [Li+].[OH-].[OH-].[Na+].[Mg+2].O1[Si]2([O-])O[Si]1([O-])O[Si]([O-])(O1)O[Si]1([O-])O2 KWLMIXQRALPRBC-UHFFFAOYSA-L 0.000 description 1
- 229910000271 hectorite Inorganic materials 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- 229940100463 hexyl laurate Drugs 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 229960002885 histidine Drugs 0.000 description 1
- 229920006007 hydrogenated polyisobutylene Polymers 0.000 description 1
- 229920003063 hydroxymethyl cellulose Polymers 0.000 description 1
- 229940031574 hydroxymethyl cellulose Drugs 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229920000592 inorganic polymer Polymers 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 229940094522 laponite Drugs 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- XCOBTUNSZUJCDH-UHFFFAOYSA-B lithium magnesium sodium silicate Chemical compound [Li+].[Li+].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Na+].[Na+].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3 XCOBTUNSZUJCDH-UHFFFAOYSA-B 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 239000008268 mayonnaise Substances 0.000 description 1
- 235000010746 mayonnaise Nutrition 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 229940114937 microcrystalline wax Drugs 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 239000012170 montan wax Substances 0.000 description 1
- 229910052901 montmorillonite Inorganic materials 0.000 description 1
- 235000011929 mousse Nutrition 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- PSZYNBSKGUBXEH-UHFFFAOYSA-N naphthalene-1-sulfonic acid Chemical compound C1=CC=C2C(S(=O)(=O)O)=CC=CC2=C1 PSZYNBSKGUBXEH-UHFFFAOYSA-N 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 229910000273 nontronite Inorganic materials 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- 239000003346 palm kernel oil Substances 0.000 description 1
- 235000019865 palm kernel oil Nutrition 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 229940088608 peg-9 polydimethylsiloxyethyl dimethicone Drugs 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 239000003504 photosensitizing agent Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920002432 poly(vinyl methyl ether) polymer Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920000768 polyamine Chemical group 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 235000010409 propane-1,2-diol alginate Nutrition 0.000 description 1
- 239000000770 propane-1,2-diol alginate Substances 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 239000008165 rice bran oil Substances 0.000 description 1
- 229910052701 rubidium Inorganic materials 0.000 description 1
- IGLNJRXAVVLDKE-UHFFFAOYSA-N rubidium atom Chemical compound [Rb] IGLNJRXAVVLDKE-UHFFFAOYSA-N 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 108700004121 sarkosyl Proteins 0.000 description 1
- 238000001878 scanning electron micrograph Methods 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 239000012176 shellac wax Substances 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 229910001388 sodium aluminate Inorganic materials 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 229960003885 sodium benzoate Drugs 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 229940072873 stearoyl glutamic acid Drugs 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 229910052712 strontium Inorganic materials 0.000 description 1
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- IMNIMPAHZVJRPE-UHFFFAOYSA-N triethylenediamine Chemical group C1CN2CCN1CC2 IMNIMPAHZVJRPE-UHFFFAOYSA-N 0.000 description 1
- 229960004799 tryptophan Drugs 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000010497 wheat germ oil Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Inorganic Compounds Of Heavy Metals (AREA)
Abstract
Description
本発明は、表面処理酸化亜鉛粉体及びその用途に関する。より詳しくは、表面処理された酸化亜鉛粉体、これを用いた分散体及び化粧料に関する。 The present invention relates to a surface-treated zinc oxide powder and use thereof. More specifically, the present invention relates to a surface-treated zinc oxide powder, a dispersion using the same, and a cosmetic.
酸化亜鉛は亜鉛華とも称され、例えばナノサイズの微粒子酸化亜鉛は紫外線遮蔽効果や可視光透明性を奏することに由来して、化粧料や塗料、プラスチック等の様々な用途に広く使用されている。酸化亜鉛は、他の配合材料との馴染みを良くする目的で表面処理されることが多く、化粧料用途ではシリコーン処理が施されることが多い(例えば特許文献1参照)。シリコーン以外ではアミノ酸処理を施すことも提案されている(例えば特許文献2、3参照)。また、微粒子酸化亜鉛は、ナノサイズであるがために粒子間の凝集力が強いことから、配合前にビーズミル等で液状分散媒に分散させることが一般的である。 Zinc oxide is also called zinc white. For example, nano-sized fine zinc oxide is widely used in various applications such as cosmetics, paints, plastics, etc. due to its UV shielding effect and visible light transparency. . Zinc oxide is often surface-treated for the purpose of improving compatibility with other compounding materials, and silicone treatment is often applied for cosmetic applications (see, for example, Patent Document 1). It has also been proposed to perform amino acid treatment other than silicone (see, for example, Patent Documents 2 and 3). In addition, since the fine zinc oxide is nano-sized and has a strong cohesive force between particles, it is generally dispersed in a liquid dispersion medium by a bead mill or the like before blending.
上述のとおり、酸化亜鉛はシリコーン処理が施されることが多いが、シリコーン処理は強い撥水性を与えるため、使い終わった後に石鹸等で落としにくいという課題があった。一方、アミノ酸処理は肌との密着性もよく、比較的洗浄しやすい。しかし、本発明者らが鋭意検討を重ねるうち、従来のアミノ酸処理を施した酸化亜鉛では、高粘度となって有機溶媒に液状状態で分散できないことや、分散体が得られた場合でも、経時で増粘したり、粒子が凝集して結果的に粒度が大きくなったりすることを見いだした。粒子の凝集は、例えば分散体を化粧料用途の原料として使用した場合に、化粧料を肌に塗布した際の仕上がりが想定外に白くなったり、感触が悪化したりするおそれを高めるため、この点に課題があった。 As mentioned above, zinc oxide is often subjected to silicone treatment, but since silicone treatment gives strong water repellency, there is a problem that it is difficult to remove with soap or the like after use. On the other hand, amino acid treatment has good adhesion to the skin and is relatively easy to clean. However, as the inventors of the present invention intensively studied, zinc oxide subjected to conventional amino acid treatment has a high viscosity and cannot be dispersed in an organic solvent in a liquid state, or even when a dispersion is obtained, It has been found that the viscosity is increased and the particles are aggregated, resulting in an increase in particle size. Aggregation of particles increases the risk that the finish when the cosmetic is applied to the skin, for example, when the dispersion is used as a raw material for cosmetics, may become unexpectedly white or feel worse. There was a problem in the point.
本発明は、上記現状に鑑み、有機溶媒への分散性が高く、粒度が細かく低粘度の分散体を与えることができる表面処理酸化亜鉛粉体を提供することを目的とする。本発明はまた、この表面処理酸化亜鉛粉体を用いた分散体及び化粧料を提供することも目的とする。 In view of the above situation, an object of the present invention is to provide a surface-treated zinc oxide powder that has a high dispersibility in an organic solvent and can provide a dispersion having a fine particle size and a low viscosity. Another object of the present invention is to provide a dispersion and a cosmetic using the surface-treated zinc oxide powder.
本発明者らは、上述のとおり酸化亜鉛の表面処理について検討を重ね、表面がN−アシル化アミノ酸塩で処理された酸化亜鉛粉体とすれば、感触が良好で高撥水性も得られると考えたが、N−アシル化アミノ酸塩を通常の方法で表面処理しても、シリコーン油等の有機溶媒に分散させることができず分散体が得られないことや、低粘度の分散体が得られても粒度が大きくなり、実用化に適さないといったことが多々生じることを見いだした。そこで更に検討を進めるうち、表面処理酸化亜鉛粉体の赤外分光法による所定ピーク間での強度比を所定範囲内にすれば、すなわち具体的には、2895〜2953cm−1での最大ピークの強度Aと、870〜886cm−1での最大ピークの強度Bとの比(A/B)を0.60〜1.20の範囲内にすれば、シリコーン油等の有機溶媒への分散性が飛躍的に向上し、粒度が細かく低粘度の分散体を与えることを新たに見いだした。但し、この強度比がこの範囲内にあっても、表面処理剤としてよく使用される酸化アルミで被覆した酸化亜鉛粉体のように、アルミニウム元素を含むと、有機溶媒への分散性が低下し、分散体としたときに粒度や粘度が著しく大きくなることも見いだし、アルミニウム元素非含有の表面処理酸化亜鉛粉体とすればこの問題が解消されることを見いだした。また、この表面処理酸化亜鉛粉体を用いた化粧料は、仕上がりが白くなることなく、感触が良好で、汗や水に強い撥水性の高い化粧料となることも見いだし、上記課題をみごとに解決することができることに想到した。このようにして本発明を完成するに至った。 As described above, the inventors of the present invention have repeatedly studied the surface treatment of zinc oxide, and if the surface is made of zinc oxide powder treated with an N-acylated amino acid salt, the feel is good and high water repellency is obtained. Although I thought, even if the N-acylated amino acid salt was surface-treated by a usual method, it could not be dispersed in an organic solvent such as silicone oil, and a dispersion could not be obtained, or a low-viscosity dispersion was obtained. However, it has been found that there are many cases where the particle size becomes large and is not suitable for practical use. Therefore, as the investigation proceeds further, if the intensity ratio between the predetermined peaks by the infrared spectroscopy of the surface-treated zinc oxide powder is within a predetermined range, that is, specifically, the maximum peak at 2895 to 2953 cm −1. If the ratio (A / B) between the strength A and the maximum peak strength B at 870 to 886 cm −1 is in the range of 0.60 to 1.20, the dispersibility in an organic solvent such as silicone oil can be improved. It has been found that it is dramatically improved and gives a dispersion with a fine particle size and a low viscosity. However, even if this strength ratio is within this range, dispersibility in an organic solvent is reduced if an aluminum element is contained, such as zinc oxide powder coated with aluminum oxide often used as a surface treatment agent. It has also been found that the particle size and viscosity are remarkably increased when a dispersion is formed, and that this problem can be solved by using a surface-treated zinc oxide powder containing no aluminum element. In addition, the cosmetics using the surface-treated zinc oxide powder have been found to have a good feel without causing the finish to be white, and to be a highly water-repellent cosmetic that is resistant to sweat and water. I came up with a solution. In this way, the present invention has been completed.
すなわち本発明は、表面がN−アシル化アミノ酸塩で処理されてなり、赤外分光法で測定した際に、2895〜2953cm−1での最大ピークの強度Aと、870〜886cm−1での最大ピークの強度Bとの比(A/B)が0.60〜1.20の範囲内であり、アルミニウム元素を含まない表面処理酸化亜鉛粉体である。 That is, the present invention, the surface is treated with N- acylated amino acid salt, when measured by infrared spectroscopy, and strength A of the maximum peak at 2895~2953Cm -1, in 870~886Cm -1 The ratio of the maximum peak intensity B (A / B) is in the range of 0.60 to 1.20, and the surface-treated zinc oxide powder does not contain an aluminum element.
上記粉体の平均一次粒子径は、10〜100nmであることが好ましい。
上記N−アシル化アミノ酸塩は、ココイルグルタミン酸塩であることが好ましい。
The average primary particle size of the powder is preferably 10 to 100 nm.
The N-acylated amino acid salt is preferably cocoyl glutamate.
本発明はまた、上記表面処理酸化亜鉛粉体と、有機溶媒とを含む分散体であって、該分散体は、粒度分布におけるD90が1000nm以下であり、粉体濃度が40質量%以上である分散体でもある。 The present invention is also a dispersion containing the surface-treated zinc oxide powder and an organic solvent, wherein the dispersion has a D90 in a particle size distribution of 1000 nm or less and a powder concentration of 40% by mass or more. It is also a dispersion.
上記有機溶媒は、シリコーン油を含むことが好ましい。 The organic solvent preferably contains silicone oil.
本発明は更に、上記分散体を含む化粧料でもある。 The present invention is also a cosmetic containing the dispersion.
本発明の表面処理酸化亜鉛粉体は、有機溶媒への分散性が高いものであり、粒度が細かく低粘度の分散体を与えることができる。このような分散体は、肌に塗布した際の感触が良好で、汗や水に強い撥水性の高い化粧料を与えることができるため、化粧料原料として特に有用である。また、化粧料だけでなく、インクや塗料の原料としても、本発明の表面処理酸化亜鉛粉体やそれを用いた分散体は有用である。 The surface-treated zinc oxide powder of the present invention has high dispersibility in an organic solvent, and can give a dispersion having a fine particle size and a low viscosity. Such a dispersion is particularly useful as a cosmetic raw material because it has a good feel when applied to the skin and can provide a highly water-repellent cosmetic material that is resistant to sweat and water. Moreover, the surface-treated zinc oxide powder of the present invention and a dispersion using the same are useful not only for cosmetics but also as raw materials for inks and paints.
以下、本発明の一例について具体的に説明するが、本発明は以下の記載のみに限定されるものではなく、本発明の要旨を変更しない範囲で適宜変更して適用することができる。 Hereinafter, an example of the present invention will be specifically described. However, the present invention is not limited to the following description, and can be applied with appropriate modifications within a range not changing the gist of the present invention.
1、表面処理酸化亜鉛粉体
本発明の表面処理酸化亜鉛粉体は、表面がN−アシル化アミノ酸塩で処理されてなる酸化亜鉛粉体である。すなわち、酸化亜鉛粉体の一部又は全部の表面が、N−アシル化アミノ酸塩で処理されることにより得られるものである。
1. Surface-treated zinc oxide powder The surface-treated zinc oxide powder of the present invention is a zinc oxide powder whose surface is treated with an N-acylated amino acid salt. That is, a part or all of the surface of the zinc oxide powder is obtained by treatment with an N-acylated amino acid salt.
N−アシル化アミノ酸塩を構成するN−アシル化アミノ酸は、アミノ酸部と脂肪酸部で構成される。アミノ酸部のアミノ酸としては例えば、グリシン、α−アラニン、バリン、ロイシン、イソロイシン、セリン、トレオニン、リジン、アルギニン、アスパラギン酸、グルタミン酸、アスパラギン、グルタミン、システイン、シスチン、メチオニン、フェニルアラニン、チロシン、プロリン、ヒドロキシプロリン、トリプトファン、ヒスチジン、β−アラニン、ε−アミノカプロン酸、ザルコシン、DL−ピログルタミン酸等が挙げられる。脂肪酸部の脂肪酸としては例えば、ラウリン酸、ミリスチン酸、パルミチン酸、ステアリン酸、オレイン酸、ヤシ油脂肪酸等が挙げられる。 The N-acylated amino acid constituting the N-acylated amino acid salt is composed of an amino acid part and a fatty acid part. Examples of amino acids in the amino acid part include glycine, α-alanine, valine, leucine, isoleucine, serine, threonine, lysine, arginine, aspartic acid, glutamic acid, asparagine, glutamine, cysteine, cystine, methionine, phenylalanine, tyrosine, proline, hydroxy Examples include proline, tryptophan, histidine, β-alanine, ε-aminocaproic acid, sarcosine, DL-pyroglutamic acid and the like. Examples of the fatty acid in the fatty acid part include lauric acid, myristic acid, palmitic acid, stearic acid, oleic acid, and coconut oil fatty acid.
上記N−アシル化アミノ酸として具体的には、ラウロイルグルタミン酸、ミリストイルグルタミン酸、ヤシ油脂肪酸グルタミン酸(ココイルグルタミン酸とも称す)、ステアロイルグルタミン酸、ラウロイルアスパラギン酸、ラウロイルサルコシン、ミリストイルサルコシン、ヤシ油脂肪酸サルコシン、N−ラウリル−N−メチル−β−アラニン、ココイルアラニン、N−ミリストイル−N−メチル−β−アラニン、N−ヤシ油脂肪酸−N−メチル−β−アラニン、ココイルグリシン等が挙げられる。中でも、ココイルグルタミン酸が好ましい。すなわち本発明のN−アシル化アミノ酸塩は、ココイルグルタミン酸塩であることが好適である。 Specific examples of the N-acylated amino acid include lauroyl glutamic acid, myristoyl glutamic acid, coconut oil fatty acid glutamic acid (also referred to as cocoyl glutamic acid), stearoyl glutamic acid, lauroyl aspartic acid, lauroyl sarcosine, myristoyl sarcosine, coconut oil fatty acid sarcosine, N-lauryl. -N-methyl-β-alanine, cocoylalanine, N-myristoyl-N-methyl-β-alanine, N-coconut oil fatty acid-N-methyl-β-alanine, cocoylglycine and the like. Among these, cocoyl glutamic acid is preferable. That is, the N-acylated amino acid salt of the present invention is preferably cocoyl glutamate.
N−アシル化アミノ酸塩としては特に限定されず、例えば、N−アシル化アミノ酸の金属塩、アンモニウム塩、有機アミン塩が好ましい。金属塩を構成する金属原子としては、例えば、ナトリウム、リチウム、カリウム、ルビジウム、セシウム等の1価金属;亜鉛、マグネシウム、カルシウム、ストロンチウム、バリウム等の2価金属;アルミニウム等の3価金属;鉄、チタン等のその他の金属;等が挙げられる。有機アミン塩を構成する有機アミン基としては、例えば、モノエタノールアミン基、ジエタノールアミン基、トリエタノールアミン基等のアルカノールアミン基;モノエチルアミン基、ジエチルアミン基、トリエチルアミン基等のアルキルアミン基;エチレンジアミン基、トリエチレンジアミン基等のポリアミン基;等が挙げられる。上記塩の中でも好ましくは、アンモニウム塩、ナトリウム塩又はカリウム塩であり、より好ましくはナトリウム塩である。 The N-acylated amino acid salt is not particularly limited, and for example, metal salts, ammonium salts, and organic amine salts of N-acylated amino acids are preferable. Examples of metal atoms constituting the metal salt include monovalent metals such as sodium, lithium, potassium, rubidium and cesium; divalent metals such as zinc, magnesium, calcium, strontium and barium; trivalent metals such as aluminum; iron And other metals such as titanium; and the like. Examples of the organic amine group constituting the organic amine salt include alkanolamine groups such as monoethanolamine group, diethanolamine group and triethanolamine group; alkylamine groups such as monoethylamine group, diethylamine group and triethylamine group; ethylenediamine group, And polyamine groups such as a triethylenediamine group. Among the above salts, ammonium salts, sodium salts, and potassium salts are preferable, and sodium salts are more preferable.
N−アシル化アミノ酸塩による表面処理では、処理後の酸化亜鉛粉体(表面処理酸化亜鉛粉体)の総量中、0.1〜10質量%の割合で表面処理が施されることが好適である。0.1質量%以上であることで、撥水性や耐水性がより向上する。なお、10質量%を超えても表面処理の効果が頭打ちとなる。より好ましくは0.2〜9質量%、更に好ましくは0.5〜8質量%である。 In the surface treatment with the N-acylated amino acid salt, the surface treatment is preferably performed at a ratio of 0.1 to 10% by mass in the total amount of the zinc oxide powder after the treatment (surface-treated zinc oxide powder). is there. When the content is 0.1% by mass or more, water repellency and water resistance are further improved. In addition, even if it exceeds 10 mass%, the effect of surface treatment reaches a peak. More preferably, it is 0.2-9 mass%, More preferably, it is 0.5-8 mass%.
表面処理酸化亜鉛粉体は、赤外分光法で測定した際に、2895〜2953m−1での最大ピークの強度Aと、870〜886cm−1での最大ピークの強度Bとの比(A/B)が0.60〜1.20の範囲内となるものである。この強度比(IR比とも称す)が0.60〜1.20の範囲外にあると、有機溶媒に分散させることができず分散体が得られないことや、低粘度の分散体が得られても粒度が大きくなり、実用化に適さないことがある。IR比は、好ましくは0.65〜1.50、より好ましくは0.70〜1.20である。
なお、各ピーク強度は、後述する実施例に記載する方法に従って求めることができる。
Surface treated zinc oxide powder, when measured by infrared spectroscopy, the ratio of the intensity A of the maximum peak at 2895~2953M -1, the intensity B of the maximum peak at 870~886cm -1 (A / B) is in the range of 0.60 to 1.20. If the intensity ratio (also referred to as IR ratio) is outside the range of 0.60 to 1.20, it cannot be dispersed in an organic solvent and a dispersion cannot be obtained, or a low viscosity dispersion can be obtained. However, the particle size becomes large and may not be suitable for practical use. The IR ratio is preferably 0.65 to 1.50, more preferably 0.70 to 1.20.
In addition, each peak intensity can be calculated | required according to the method described in the Example mentioned later.
ここで、上記IR比の変化が具体的に何を示しているのかは不明であるが、2895〜2953cm−1での最大ピークはアミノ酸のC−Hの分子運動に、870〜886cm−1での最大ピークはZn−Oの分子運動にそれぞれ起因するため、酸化亜鉛と表面のN−アシル化アミノ酸塩との化学的な相互作用に由来していると予想される。後述の実施例に示すように、強熱減量から乾燥減量を差し引いて算出した表面処理量は実施例と比較例とで殆ど違いがないため、単純にN−アシル化アミノ酸塩と酸化亜鉛との重量比では説明できないことは明らかである。この点から、以下のように推測できる。
すなわちIR比(A/B)が0.60〜1.20の範囲内にあると、立体的な障害によりアミノ酸のC−Hが伸縮振動をしにくい状況下にある。つまりC−Hが密になっており、それゆえN−アシル化アミノ酸塩による表面処理が均一になっている可能性がある。
一方、IR比が1.20より高い場合は、アミノ酸のC−Hが伸縮振動がしやすい状況にある。立体的な障害が少ないと考えられ、アミノ酸同士が離れているものが多いため、N−アシル化アミノ酸塩による処理が不均一になっていると予想される。またIR比が0.60より低い場合には、C−Hの量がそもそも減っているため、コアである酸化亜鉛が露出し、表面処理が不均一になっていると予想される。
なお、上記IR比は、例えば表面処理条件を調整することで制御可能である。
Here, it is unclear what the change in the IR ratio specifically indicates, but the maximum peak at 2895 to 2953 cm −1 is due to molecular movement of the amino acid C—H at 870 to 886 cm −1 . Since the maximum peak of is attributed to the molecular motion of Zn—O, it is expected to be derived from the chemical interaction between zinc oxide and the surface N-acylated amino acid salt. As shown in the examples described later, the surface treatment amount calculated by subtracting the loss on drying from the loss on ignition is almost the same between the example and the comparative example, so that the N-acylated amino acid salt and zinc oxide are simply different. It is clear that the weight ratio cannot be explained. From this point, it can be estimated as follows.
That is, when the IR ratio (A / B) is in the range of 0.60 to 1.20, the amino acid C—H is not easily stretched and contracted due to steric hindrance. That is, C—H is dense, and therefore the surface treatment with the N-acylated amino acid salt may be uniform.
On the other hand, when the IR ratio is higher than 1.20, the amino acid C—H is likely to undergo stretching vibration. It is considered that there are few steric hindrances, and since many amino acids are separated from each other, it is expected that the treatment with the N-acylated amino acid salt is uneven. Further, when the IR ratio is lower than 0.60, the amount of C—H is originally reduced, so that it is expected that the zinc oxide as the core is exposed and the surface treatment is uneven.
The IR ratio can be controlled by adjusting surface treatment conditions, for example.
表面処理酸化亜鉛粉体はまた、アルミニウム元素を含まない。
「アルミニウム元素を含まない」(「アルミニウム非含有」とも称す)とは、表面処理酸化亜鉛粉体の総質量中、アルミニウム元素の含有量が0.1%以下、つまりは0.1質量%以下であることを意味する。例えば表面処理無機粉体では、予め水酸化アルミニウムやアルミナで無機粉体の表面を被覆した後、他の表面処理剤で表面を処理することが多いが、本発明でこれを行うと、IR比が上記範囲内にあっても、有機溶媒への分散性が低下し、分散体としたときに粒度や粘度が著しく大きくなる。その理由は定かではないが、おそらく、酸化亜鉛と表面のN−アシル化アミノ酸塩との化学的な相互作用が阻害されることに起因すると考えられる。
アルミニウム元素の含有量は、塩酸等の適当な酸に溶解後に、原子吸光光度計やICP元素分析装置を用いる等の一般の元素分析法により求めることができる。
The surface-treated zinc oxide powder also does not contain an aluminum element.
“No aluminum element” (also referred to as “non-aluminum”) means that the content of aluminum element in the total mass of the surface-treated zinc oxide powder is 0.1% or less, that is, 0.1% by mass or less. It means that. For example, in a surface-treated inorganic powder, the surface of the inorganic powder is previously coated with aluminum hydroxide or alumina, and then the surface is often treated with another surface treatment agent. Is within the above range, the dispersibility in an organic solvent is lowered, and the particle size and viscosity are remarkably increased when a dispersion is obtained. The reason for this is not clear, but it is probably due to the inhibition of the chemical interaction between zinc oxide and the surface N-acylated amino acid salt.
The content of the aluminum element can be determined by a general elemental analysis method such as using an atomic absorption photometer or an ICP elemental analyzer after being dissolved in a suitable acid such as hydrochloric acid.
表面処理酸化亜鉛粉体は、平均一次粒子径が1〜100nmであることが好ましい。これにより紫外線遮蔽性や可視光透明性を高めることができるため、化粧料用途により適したものとなる。より好ましくは10〜100nm、更に好ましくは10〜50nmである。
なお、平均一次粒子径は、走査型電子顕微鏡写真(SEM写真)でランダムに選択した200個の粒子の一次粒子径を測定し、その一次粒子径の平均を算出するという方法によって測定された値を意味する。個々の一次粒子径の算出には最小外接円の直径を使用する。
The surface-treated zinc oxide powder preferably has an average primary particle size of 1 to 100 nm. Thereby, the ultraviolet shielding property and the visible light transparency can be improved, so that it is more suitable for cosmetic use. More preferably, it is 10-100 nm, More preferably, it is 10-50 nm.
The average primary particle size is a value measured by a method of measuring the primary particle size of 200 particles randomly selected in a scanning electron micrograph (SEM photo) and calculating the average of the primary particle sizes. Means. The diameter of the smallest circumscribed circle is used to calculate the individual primary particle size.
表面処理酸化亜鉛粉体は、比表面積(BET比表面積を意味する)が10〜80m2/gであることが好ましい。これにより強度がより充分なものとなり、感触がより良好なものとなる。より好ましくは20〜70m2/g、更に好ましくは25〜65m2/gである。
なお、上記比表面積は、後述する実施例に記載する方法に従って求めることができる。
The surface-treated zinc oxide powder preferably has a specific surface area (meaning a BET specific surface area) of 10 to 80 m 2 / g. As a result, the strength becomes more satisfactory and the feel becomes better. More preferably, it is 20-70 m < 2 > / g, More preferably, it is 25-65 m < 2 > / g.
In addition, the said specific surface area can be calculated | required according to the method described in the Example mentioned later.
表面処理酸化亜鉛粉体の形状は特に限定されず、例えば、球状(略球状も含む)、棒状、針状、紡錘状、板状、六角板状、針状凝集体、無定形状等が挙げられる。中でも球状(略球状を含む)が好ましい。形状は、走査型電子顕微鏡等によって観察することができる。 The shape of the surface-treated zinc oxide powder is not particularly limited, and examples thereof include a spherical shape (including a substantially spherical shape), a rod shape, a needle shape, a spindle shape, a plate shape, a hexagonal plate shape, an acicular aggregate, and an amorphous shape. It is done. Of these, spherical (including substantially spherical) is preferable. The shape can be observed with a scanning electron microscope or the like.
2、表面処理酸化亜鉛粉体の製造方法
本発明において、N−アシル化アミノ酸塩を酸化亜鉛粉体表面に処理する方法(すなわち本発明の表面処理酸化亜鉛粉体の製造方法)としては、表面処理酸化亜鉛粉体の赤外分光法による所定ピーク間での強度比について、2895〜2953cm−1での最大ピークの強度Aと、870〜886cm−1での最大ピークの強度Bとの比(A/B)が0.60〜1.20の範囲内であれば、特に限定されるものではなく、通常公知の処理方法が用いられる。具体的には、例えば、N−アシル化アミノ酸塩を直接酸化亜鉛粉体と混合する方法(乾式処理法、メカノケミカル法)、N−アシル化アミノ酸塩を分散媒に分散させてから酸化亜鉛粉体に混合する方法(半乾式法)、酸化亜鉛粉体を分散媒に分散させてスラリーを作製してから混合する方法(湿式法)等が挙げられる。
2. Method for producing surface-treated zinc oxide powder In the present invention, the method for treating the surface of zinc oxide powder with an N-acylated amino acid salt (that is, the method for producing the surface-treated zinc oxide powder of the present invention) ratio for the intensity ratio between a given peak by infrared spectroscopy treated zinc oxide powder, and the intensity a of the maximum peak at 2895~2953Cm -1, and the intensity of the maximum peak at 870~886cm -1 B ( If A / B) is in the range of 0.60 to 1.20, it is not particularly limited, and generally known processing methods are used. Specifically, for example, a method in which an N-acylated amino acid salt is directly mixed with zinc oxide powder (dry treatment method, mechanochemical method), an N-acylated amino acid salt is dispersed in a dispersion medium, and then zinc oxide powder is mixed. Examples thereof include a method of mixing with a body (semi-dry method), a method of mixing a zinc oxide powder in a dispersion medium to prepare a slurry (wet method), and the like.
原料の酸化亜鉛粉体は特に限定されないが、平均粒子径が1〜100nmであることが好ましい。より好ましくは10〜100nm、更に好ましくは10〜50nmでる。
なお、スラリー中の酸化亜鉛の平均一次粒子径を計測する場合は、スラリーをろ過、水洗後、定温乾燥機(アズワン社製、SONW−450)を用いて105℃、2時間で乾燥して得られた粒子を使用する。
The raw material zinc oxide powder is not particularly limited, but the average particle size is preferably 1 to 100 nm. More preferably, it is 10-100 nm, More preferably, it is 10-50 nm.
In addition, when measuring the average primary particle diameter of zinc oxide in the slurry, the slurry is filtered, washed with water, and then dried at 105 ° C. for 2 hours using a constant temperature dryer (manufactured by ASONE, SONW-450). Use the particles produced.
表面処理に供される各成分の使用量は、上述した表面処理量を満たすように適宜設定することが好適である。表面処理の方法によっては処理中あるいは処理後に表面処理剤のロスが発生することがあるため、例えば、酸化亜鉛粉体100質量部に対し、N−アシル化アミノ酸塩を0.1〜15質量部とすることが好ましい。より好ましくは0.2〜12質量部、更に好ましくは0.5〜10質量部である。 The amount of each component used for the surface treatment is preferably set as appropriate so as to satisfy the surface treatment amount described above. Depending on the surface treatment method, loss of the surface treatment agent may occur during or after the treatment. For example, 0.1 to 15 parts by mass of an N-acylated amino acid salt with respect to 100 parts by mass of the zinc oxide powder. It is preferable that More preferably, it is 0.2-12 mass parts, More preferably, it is 0.5-10 mass parts.
表面処理に際しては、各原料が均一に混合された状態になるように、充分に撹拌することが好ましい。上記乾式法、半乾式法でミキサーを使用する場合には、回転数を高めて撹拌することが好ましい。撹拌時間にもよるが、回転数を例えば1000rpm以上とすることが好ましい。より好ましくは2000rpm以上である。回転数が500rpm以下であると表面処理がうまくいかないことがある。なお、表面処理温度は特に限定されないが、例えば作業面からは、5〜150℃で行うことが好ましく、60〜150℃で行うことが更に好ましい。 In the surface treatment, it is preferable to sufficiently stir so that the raw materials are uniformly mixed. When using a mixer by the dry method or semi-dry method, it is preferable to increase the number of rotations and stir. Although depending on the stirring time, it is preferable to set the number of rotations to, for example, 1000 rpm or more. More preferably, it is 2000 rpm or more. If the rotational speed is 500 rpm or less, the surface treatment may not be successful. The surface treatment temperature is not particularly limited, but for example, from the work surface, it is preferably performed at 5 to 150 ° C, more preferably 60 to 150 ° C.
上記半乾式法や湿式法で使用される分散媒としては特に限定されないが、例えば、水、有機溶媒又はこれらの混合物等が挙げられる。有機溶媒としては、アルコール、アセトン、ジメチルスルホキシド、ジメチルホルムアミド、テトラヒドロフラン、ジオキサン等が挙げられ、アルコールとしては、メタノール、エタノール、プロパノール等の1価の水溶性アルコール;エチレングリコール、グリセリン等の2価以上の水溶性アルコール;等が挙げられる。分散媒として好ましくは水であり、より好ましくはイオン交換水である。 Although it does not specifically limit as a dispersion medium used with the said semi-dry method and a wet method, For example, water, an organic solvent, or these mixtures etc. are mentioned. Examples of the organic solvent include alcohol, acetone, dimethyl sulfoxide, dimethylformamide, tetrahydrofuran, dioxane and the like. Examples of the alcohol include monovalent water-soluble alcohols such as methanol, ethanol and propanol; bivalent or more such as ethylene glycol and glycerin. Of water-soluble alcohols. The dispersion medium is preferably water, and more preferably ion-exchanged water.
上記湿式法ではスラリーを作製した後、スラリーを80℃以上で熟成することが好ましい。これにより、より好ましくは85℃以上、更に好ましくは90℃以上である。熟成温度の上限はアミノ酸の分解を抑制するために、200℃以下とすることが好ましい。より好ましくは150℃以下、更に好ましくは130℃以下である。なお、スラリーを撹拌しながら熟成することが好適である。 In the above wet method, it is preferable to ripen the slurry at 80 ° C. or higher after preparing the slurry. Thereby, More preferably, it is 85 degreeC or more, More preferably, it is 90 degreeC or more. The upper limit of the aging temperature is preferably 200 ° C. or lower in order to suppress the degradation of amino acids. More preferably, it is 150 degrees C or less, More preferably, it is 130 degrees C or less. It is preferable to age the slurry while stirring.
熟成時間は特に限定されないが、1分以上とすることが好ましい。より好ましくは5分以上、更に好ましくは10分以上である。熟成時間の上限は特に限定されないが、例えば、製造効率向上の観点からは、10時間以下とすることが好ましい。より好ましくは5時間以下、更に好ましくは2時間以下である。
本明細書中、熟成温度とは、熟成時の最高温度を意味する。また、熟成時間とは、熟成時の最高温度(熟成温度)の保持時間を意味し、最高温度に達するまでの昇温時間は含まない。昇温時間は特に限定されないが、できるだけ短くすることが好適である。
The aging time is not particularly limited, but is preferably 1 minute or longer. More preferably, it is 5 minutes or more, More preferably, it is 10 minutes or more. The upper limit of the aging time is not particularly limited, but is preferably 10 hours or less from the viewpoint of improving production efficiency, for example. More preferably, it is 5 hours or less, More preferably, it is 2 hours or less.
In the present specification, the aging temperature means the maximum temperature during aging. The aging time means a holding time of the maximum temperature (aging temperature) at the time of aging, and does not include a temperature raising time until the maximum temperature is reached. The temperature raising time is not particularly limited, but is preferably as short as possible.
上記湿式法では、スラリーを熟成後、分散媒を除去することが好適である。また、必要に応じて、中和、洗浄、粉砕等の他、通常の粒子の表面処理等で行われる他の工程を更に行ってもよい。 In the wet method, it is preferable to remove the dispersion medium after aging the slurry. Moreover, you may further perform other processes performed by surface treatment etc. of normal particle | grains other than neutralization, washing | cleaning, grinding | pulverization, etc. as needed.
上記分散媒除去後に乾燥を行うことも好適である。乾燥は、真空乾燥、加熱乾燥等があるが、加熱乾燥を行う場合は、温度35℃〜200℃で5分〜72時間行うことが好ましい。乾燥を行うことで、N−アシル化アミノ酸塩を表面処理した酸化亜鉛粒子(すなわち本発明の表面処理酸化亜鉛粉体)の分散性がより向上することが期待される。 It is also preferable to perform drying after removing the dispersion medium. Drying includes vacuum drying, heat drying, and the like. When heat drying is performed, it is preferably performed at a temperature of 35 ° C. to 200 ° C. for 5 minutes to 72 hours. By performing the drying, it is expected that the dispersibility of the zinc oxide particles surface-treated with the N-acylated amino acid salt (that is, the surface-treated zinc oxide powder of the present invention) is further improved.
3、分散体
本発明の分散体は、上述した本発明の表面処理酸化亜鉛粉体と、有機溶媒とを含む。上述したとおり、表面処理酸化亜鉛粉体は有機溶媒への分散性が良好であるため、本発明の分散体は、有機溶媒中で表面処理酸化亜鉛粉体が均一かつ安定して分散した状態となる。それゆえ、細かい粒度の表面処理酸化亜鉛粉体を高濃度に分散させても低粘度を実現できるため、化粧料用途等の種々の用途に有用である。なお、必要に応じて他の成分を含んでもよく、各含有成分は、それぞれ1種又は2種以上を使用することができる。
3. Dispersion The dispersion of the present invention contains the above-described surface-treated zinc oxide powder of the present invention and an organic solvent. As described above, since the surface-treated zinc oxide powder has good dispersibility in an organic solvent, the dispersion of the present invention has a state in which the surface-treated zinc oxide powder is uniformly and stably dispersed in the organic solvent. Become. Therefore, a low viscosity can be realized even when a surface-treated zinc oxide powder having a fine particle size is dispersed at a high concentration, which is useful for various uses such as cosmetics. In addition, you may contain another component as needed, and each containing component can use 1 type (s) or 2 or more types, respectively.
上記分散体は、粉体濃度が40質量%以上である。すなわち本発明の表面処理酸化亜鉛粉体の含有量(粉体濃度)は、分散体の総質量の40%以上である。これにより、各種用途で原料として分散体を使用した場合に、少量で充分な効果を発揮できるため好適である。分散安定性の観点から、好ましくは40〜80質量%、より好ましくは50〜70質量%である。 The dispersion has a powder concentration of 40% by mass or more. That is, the content (powder concentration) of the surface-treated zinc oxide powder of the present invention is 40% or more of the total mass of the dispersion. Thereby, when a dispersion is used as a raw material in various applications, a sufficient effect can be exhibited with a small amount, which is preferable. From the viewpoint of dispersion stability, it is preferably 40 to 80% by mass, more preferably 50 to 70% by mass.
上記分散体において、有機溶媒は特に限定されず、例えば、パルミチン酸エチルヘキシル、イソノナン酸トリイソデシル等のエステル油;アルコール;水添ポリイソブテン等の流動パラフィン;シクロペンタシロキサン、デカメチルシクロペンタシロキサン等のシリコーン油;等が挙げられる。中でも、シリコーン油が好ましく、これにより上記分散体が化粧料用途により有用なものとなる。有機溶媒の濃度は60質量%以下である。すなわち、分散体の総質量の60%以下であればよい。好ましくは10〜60質量%、より好ましくは20〜60質量%、更に好ましくは30〜50質量%である。 In the above dispersion, the organic solvent is not particularly limited, and examples thereof include ester oils such as ethylhexyl palmitate and triisodecyl isononanoate; alcohols; liquid paraffins such as hydrogenated polyisobutene; silicone oils such as cyclopentasiloxane and decamethylcyclopentasiloxane. And the like. Among these, silicone oil is preferable, and this makes the dispersion more useful for cosmetic use. The concentration of the organic solvent is 60% by mass or less. That is, it may be 60% or less of the total mass of the dispersion. Preferably it is 10-60 mass%, More preferably, it is 20-60 mass%, More preferably, it is 30-50 mass%.
上記分散体はまた、分散剤を含有することができる。分散剤を配合することで分散体の粘度安定化や粒度分布変化の抑制、分散粒子径の微細化等が期待できるため、含有することが好ましい。 The dispersion can also contain a dispersant. Since the dispersion can be expected to stabilize the viscosity of the dispersion, suppress the change in the particle size distribution, refine the dispersed particle size, and the like, it is preferably contained.
分散剤の種類については特に限定されず、例えば、ポリカルボン酸又はその塩、アルキルスルホン酸又はその塩、アルキルベンゼンスルホン酸又はその塩、ナフタレンスルホン酸又はその塩、ポリエーテルアルキルスルホン酸又はその塩、アルキルベタイン、ポリヒドロシステアリン酸、ポリエーテル又はその誘導体、ポリエーテルアルキルエーテル、ポリオキシアルキレンアルケニルフェニルエーテル、ソルビタン脂肪酸エステル、ポリエーテルソルビタン脂肪酸エステル、ポリエーテル脂肪酸エステル、グリセリン脂肪酸エステル、ポリエーテル硬化ヒマシ油、ポリエーテルアルキルアミン、ポリエーテル変性シリコーン、ポリグリセリン変性シリコーン、多価アルコール類、アルキル変性多価アルコール等が挙げられる。アニオン系、カチオン系、ノニオン系のどれを使用しても構わないが、酸化亜鉛粒子との化学反応を予防するためにノニオン系のものが好ましく、更にポリエーテル変性シリコーンを用いることが好ましい。 The type of the dispersant is not particularly limited, and examples thereof include polycarboxylic acid or a salt thereof, alkylsulfonic acid or a salt thereof, alkylbenzenesulfonic acid or a salt thereof, naphthalenesulfonic acid or a salt thereof, polyether alkylsulfonic acid or a salt thereof, Alkyl betaines, polyhydrostearic acids, polyethers or derivatives thereof, polyether alkyl ethers, polyoxyalkylene alkenyl phenyl ethers, sorbitan fatty acid esters, polyether sorbitan fatty acid esters, polyether fatty acid esters, glycerin fatty acid esters, polyether-cured castor Examples thereof include oil, polyether alkylamine, polyether-modified silicone, polyglycerin-modified silicone, polyhydric alcohols, and alkyl-modified polyhydric alcohol. Any of anionic, cationic, and nonionic types may be used, but nonionic type is preferable to prevent chemical reaction with zinc oxide particles, and polyether-modified silicone is more preferable.
上記分散体は、必要に応じて更に他の成分を含んでもよい。他の成分としては特に限定されないが、例えば、防菌防腐剤、抗菌剤等が挙げられる。これらの含有量も特に限定されず、例えば、20質量%以下である。すなわち分散体の総質量の20%以下であることが好ましい。より好ましくは10質量%以下である。 The dispersion may further contain other components as necessary. Although it does not specifically limit as another component, For example, antibacterial preservative, an antibacterial agent, etc. are mentioned. These contents are not particularly limited, and are, for example, 20% by mass or less. That is, it is preferably 20% or less of the total mass of the dispersion. More preferably, it is 10 mass% or less.
上記分散体は、粒度分布におけるD90が1000nm以下である。このように粒度が細かい分散体であると、例えば化粧料用途に使用した場合に、肌に塗布した際の仕上がりが白くなることなく、感触が良好なものとなるため、好適である。好ましくは950nm以下、より好ましくは930nm以下である。
なお、D90は、粒度分布において、小粒子側からの体積累積値が全粒子体積の90%になる粒径を意味する。粒度分布の測定方法は、実施例にて後述する。
The dispersion has a D90 in the particle size distribution of 1000 nm or less. Thus, when the dispersion is fine in particle size, for example, when used for cosmetics, the finish when applied to the skin does not become white, and the touch becomes favorable. Preferably it is 950 nm or less, More preferably, it is 930 nm or less.
Note that D90 means a particle size in which the volume cumulative value from the small particle side is 90% of the total particle volume in the particle size distribution. A method for measuring the particle size distribution will be described later in Examples.
上記分散体は、25℃での粘度が500mPa・s以下であることが好ましい。これにより、化粧料原料等の各種用途により好適なものとなる。より好ましくは400mPa・s以下、更に好ましくは300mPa・s以下である。
なお、分散体粘度は、後述する実施例に記載する方法に従って求めることができる。
The dispersion preferably has a viscosity at 25 ° C. of 500 mPa · s or less. Thereby, it becomes more suitable for various uses, such as cosmetic raw materials. More preferably, it is 400 mPa * s or less, More preferably, it is 300 mPa * s or less.
In addition, a dispersion viscosity can be calculated | required according to the method described in the Example mentioned later.
上記分散体を得るための製造方法としては特に限定されず、上述した成分を混合することにより作製すればよい。混合方法も限定されず、均一に分散させることができる通常の手法を採用すればよい。例えば、ビーズミル、高圧ホモジナイザー等の分散機・装置を用いてもよい。 It does not specifically limit as a manufacturing method for obtaining the said dispersion, What is necessary is just to produce by mixing the component mentioned above. The mixing method is not limited, and a normal method that can be uniformly dispersed may be employed. For example, a disperser / apparatus such as a bead mill or a high-pressure homogenizer may be used.
上記分散体は、含まれる粉体の粒度が細かく低粘度であるため、例えば化粧料用途に使用した場合には、仕上がりが白くなることなく、感触が良好で、汗や水に強い撥水性の高い化粧料を実現することができる。このように本発明の分散体からなる化粧料原料は、本発明の一つである。本発明の分散体を含む各種組成物(例えば、化粧料の他、塗料組成物、インキ組成物)もまた、本発明者による発明である。このうち化粧料について以下に説明する。 Since the above-mentioned dispersion has a fine particle size and low viscosity, for example, when used for cosmetics, the finish does not become white, the feel is good, and the water repellency is strong against sweat and water. High cosmetics can be realized. Thus, the cosmetic raw material which consists of a dispersion of this invention is one of this invention. Various compositions containing the dispersion of the present invention (for example, coating compositions and ink compositions in addition to cosmetics) are also invented by the present inventors. Of these, the cosmetic will be described below.
4、化粧料
本発明の化粧料は、上述した本発明の分散体を含む。このような化粧料の製造方法は特に限定されず、通常の化粧料の製法に従えばよい。
4. Cosmetics The cosmetic of the present invention contains the dispersion of the present invention described above. The manufacturing method of such cosmetics is not specifically limited, What is necessary is just to follow the manufacturing method of normal cosmetics.
上記化粧料としては特に限定されず、例えば、スキンケア製品、頭髪製品、メークアップ製品、紫外線防御用製品等が挙げられる。中でも、ファンデーション、サンスクリーン剤、化粧下地等として好適に使用することができる。また、形状も特に限定されず、例えば、液状、乳液状、クリーム状、固形状、ペースト状、ゲル状、多層状、ムース状、スプレー状等に適用が可能である。 The cosmetic is not particularly limited, and examples thereof include skin care products, hair products, makeup products, and UV protection products. Among them, it can be suitably used as a foundation, a sunscreen agent, a makeup base and the like. Also, the shape is not particularly limited, and can be applied to, for example, liquid, emulsion, cream, solid, paste, gel, multilayer, mousse, and spray.
本発明の化粧料は、水性化粧料、O/W型化粧料(水中油型化粧料)、W/O型化粧料(油中水型化粧料)のいずれの場合でも、好適に適用することができる。中でも、水中油型化粧料として特に好適であり、この場合には、本発明の表面処理酸化亜鉛粉体が主に水相に安定に存在することができる。それゆえ、良好な使用感、撥水性、紫外線遮断効果、可視光透明性等を安定して発揮することができるため、好適である。 The cosmetic of the present invention is preferably applied to any of water-based cosmetics, O / W type cosmetics (oil-in-water cosmetics), and W / O type cosmetics (water-in-oil cosmetics). Can do. Among them, it is particularly suitable as an oil-in-water cosmetic, and in this case, the surface-treated zinc oxide powder of the present invention can be stably present mainly in the water phase. Therefore, it is preferable because a good feeling of use, water repellency, ultraviolet ray blocking effect, visible light transparency and the like can be stably exhibited.
上記化粧料には、必要に応じて、化粧品分野で通常使用されている任意の水性成分、油性成分を1種又は2種以上含んでもよい。水性成分及び油性成分としては特に限定されないが、例えば、油剤、界面活性剤、増粘剤、防腐抗菌剤、抗菌剤、防腐剤、多価アルコール類、紫外線吸収剤、紫外線遮蔽剤、酸化防止剤、保湿剤、金属イオン封鎖剤、各種抽出液、薬剤成分、色剤(染料、顔料等)、色素、増粘剤、pH調整剤、香料、冷感剤、制汗剤、殺菌剤、皮膚賦活剤、各種粉体等が挙げられる。 If necessary, the cosmetic may contain one or more arbitrary aqueous components and oily components that are usually used in the cosmetic field. Although it does not specifically limit as an aqueous component and an oil component, For example, oil agent, surfactant, thickener, antiseptic antibacterial agent, antibacterial agent, preservative, polyhydric alcohol, ultraviolet absorber, ultraviolet shielding agent, antioxidant , Moisturizers, sequestering agents, various extracts, drug components, colorants (dyes, pigments, etc.), pigments, thickeners, pH adjusters, fragrances, cooling agents, antiperspirants, fungicides, skin activation Agents, various powders and the like.
油剤としては特に限定されず、例えば、アボガド油、ツバキ油、タートル油、マカデミアナッツ油、トウモロコシ油、ミンク油、オリーブ油、ナタネ油、卵黄油、ゴマ油、パーシック油、小麦胚芽油、サザンカ油、ヒマシ油、アマニ油、サフラワー油、綿実油、エノ油、大豆油、落花生油、茶実油、カヤ油、コメヌカ油、日本キリ油、ホホバ油、胚芽油、トリグリセリン、トリオクタン酸グリセリン、トリイソパルミチン酸グリセリン、カカオ脂、ヤシ油、馬油、パーム油、牛脂、羊脂、硬化牛脂、パーム核油、豚脂、牛骨脂、硬化油、牛脚脂、モクロウ、硬化ヒマシ油、ミツロウ、カンデリラロウ、綿ロウ、カルナウバロウ、ベイベリーロウ、イボタロウ、鯨ロウ、モンタンロウ、ヌカロウ、ラノリン、カポックロウ、酢酸ラノリン、液状ラノリン、サトウキビロウ、ラノリン脂肪酸イソプロピル、ラウリン酸ヘキシル、還元ラノリン、硬質ラノリン、セラックロウ、POEラノリンアルコールエーテル、POEラノリンアルコールアセテート、POEコレステロールエーテル、ラノリン脂肪酸ポリエチレングリコール、POE水素添加ラノリンアルコールエーテル、流動パラフィン、オゾケライト、プリスタン、パラフィン、セレシン、スクワレン、ワセリン、マイクロクリスタリンワックス等が挙げられる。 It is not particularly limited as an oil agent, for example, avocado oil, camellia oil, turtle oil, macadamia nut oil, corn oil, mink oil, olive oil, rapeseed oil, egg yolk oil, sesame oil, persic oil, wheat germ oil, Southern oil, castor oil , Linseed oil, safflower oil, cottonseed oil, eno oil, soybean oil, peanut oil, tea seed oil, kaya oil, rice bran oil, Japanese kiri oil, jojoba oil, germ oil, triglycerin, trioctanoic acid glycerin, triisopalmitic acid Glycerin, cacao butter, palm oil, horse oil, palm oil, beef tallow, sheep fat, hardened beef tallow, palm kernel oil, pork tallow, beef bone fat, hardened oil, beef leg fat, owl, hardened castor oil, beeswax, candelilla wax, Cotton wax, Carnauba wax, Bayberry wax, Ibotaro, Whale wax, Montan wax, Nukarou, Lanolin, Kapok wax, Lanolin acetate, Liquid Norin, sugar cane wax, lanolin fatty acid isopropyl, hexyl laurate, reduced lanolin, hard lanolin, shellac wax, POE lanolin alcohol ether, POE lanolin alcohol acetate, POE cholesterol ether, lanolin fatty acid polyethylene glycol, POE hydrogenated lanolin alcohol ether, liquid paraffin, Examples include ozokerite, pristane, paraffin, ceresin, squalene, petrolatum, and microcrystalline wax.
界面活性剤としては、アニオン性、カチオン性、非イオン性及び両性の界面活性剤が挙げられるが、特に制限されるものではなく、通常、化粧料に使用されるものであればいずれであってもよい。 Surfactants include anionic, cationic, nonionic and amphoteric surfactants, but are not particularly limited, and any surfactant that is usually used in cosmetics can be used. Also good.
例えば非イオン性界面活性剤としては、(ポリ)グリセリン脂肪酸エステル、ポリオキシアルキレングリセリン脂肪酸エステル、ポリオキシアルキレンソルビタン脂肪酸エステル、ポリオキシアルキレンソルビット脂肪酸エステル、ポリオキシアルキレン脂肪酸エステル、ポリオキシアルキレンソルビタン脂肪酸エステル、ポリオキシアルキレンヒマシ油、ポリオキシアルキレン硬化ヒマシ油、ポリオキシアルキレンソルビトールテトラ脂肪酸エステル、ソルビタン脂肪酸エステル、ショ糖脂肪酸エステル、ポリオキシアルキレンステロール、ポリオキシアルキレンアルキルエーテル、ポリオキシアルキレンアルキルエーテルリン酸等の他、ポリオキシアルキレン基含有オルガノポリシロキサン、ポリグリセリン基含有オルガノポリシロキサン、糖鎖含有オルガノポリシロキサン等のオルガノポリシロキサン系の非イオン界面活性剤も挙げられる。 For example, as the nonionic surfactant, (poly) glycerin fatty acid ester, polyoxyalkylene glycerin fatty acid ester, polyoxyalkylene sorbitan fatty acid ester, polyoxyalkylene sorbit fatty acid ester, polyoxyalkylene fatty acid ester, polyoxyalkylene sorbitan fatty acid ester , Polyoxyalkylene castor oil, polyoxyalkylene hydrogenated castor oil, polyoxyalkylene sorbitol tetra fatty acid ester, sorbitan fatty acid ester, sucrose fatty acid ester, polyoxyalkylene sterol, polyoxyalkylene alkyl ether, polyoxyalkylene alkyl ether phosphoric acid, etc. In addition, polyoxyalkylene group-containing organopolysiloxane, polyglycerin group-containing organopolysiloxane , Organopolysiloxane of nonionic surfactants sugar chain-containing organopolysiloxane and the like are also mentioned.
増粘剤としては特に限定されず、例えば、アラビアゴム、アラビノガラクタン、アルゲコロイド、カラギーナン、カラヤガム、寒天、グアーガム、クインスシード(マルメロ)、スクレロチウムガム、デンプン(コメ、トウモロコシ、バレイショ、コムギ)、ペクチン、トラガントガム、ローカストビーンガム(キャロブガム)等の植物系高分子;キサンタンガム、デキストラン、サクシノグルカン、プルラン等の微生物系高分子;コラーゲン、カゼイン、アルブミン、ゼラチン等の動物系高分子;カルボキシメチルデンプン、メチルヒドロキシプロピルデンプン等のデンプン系高分子;メチルセルロース、エチルセルロース、メチルヒドロキシプロピルセルロース、カルボキシメチルセルロース、ヒドロキシメチルセルロース、ヒドロキシプロピルセルロース、セルロース硫酸ナトリウム、カルボキシメチルセルロースナトリウム、結晶セルロース、微生物産生セルロース、セルロース末のセルロース系高分子;アルギン酸ナトリウム、アルギン酸プロピレングリコールエステル等のアルギン酸系高分子;ポリビニルメチルエーテル、カルボキシビニルポリマー等のビニル系高分子;ポリオキシエチレン系高分子;ポリオキシエチレンポリオキシプロピレン共重合体系高分子;ポリアクリル酸塩、アクリル酸・(メタ)アクリル酸アルキルのコポリマーやクロスポリマー、ポリアクリルアミド、アクリル酸アルキルやアクリルアミドとアクリロイルジメチルタウリン塩のコポリマー等のアクリル系高分子;ポリエチレンイミン、カチオンポリマー等他の合成高分子;シリコーン化プルラン等の半合成高分子;ベントナイト、ケイ酸アルミニウムマグネシウム、モンモリロナイト、バイデライト、ノントロナイト、ラポナイト、ヘクトライト、無水ケイ酸等の無機系高分子;等が挙げられる。 The thickening agent is not particularly limited. For example, gum arabic, arabinogalactan, arugeocolloid, carrageenan, caraya gum, agar, guar gum, quince seed (quince), sclerotium gum, starch (rice, corn, potato, wheat) ), Plant polymers such as pectin, tragacanth gum, locust bean gum (carob gum); microbial polymers such as xanthan gum, dextran, succinoglucan and pullulan; animal polymers such as collagen, casein, albumin and gelatin; carboxy Starch polymers such as methyl starch and methylhydroxypropyl starch; methylcellulose, ethylcellulose, methylhydroxypropylcellulose, carboxymethylcellulose, hydroxymethylcellulose, hydroxy Cellulose polymers such as propyl cellulose, sodium cellulose sulfate, sodium carboxymethyl cellulose, crystalline cellulose, cellulose produced by microorganisms, cellulose powder; alginic acid polymers such as sodium alginate and propylene glycol alginate; polyvinyl methyl ether, carboxyvinyl polymer, etc. Vinyl polymers; polyoxyethylene polymers; polyoxyethylene polyoxypropylene copolymer polymers; polyacrylates, copolymers of acrylic acid and alkyl (meth) acrylates and cross polymers, polyacrylamides, alkyl acrylates And acrylic polymers such as acrylamide and acryloyl dimethyl taurate copolymers; other synthetic polymers such as polyethyleneimine and cationic polymers; Semisynthetic polymers such as Ruran; and the like; bentonite, aluminum magnesium silicate, montmorillonite, beidellite, nontronite, laponite, hectorite, inorganic polymers such as anhydrous silicic acid.
防腐抗菌剤、抗菌剤としては特に限定されず、例えば、パラオキシ安息香酸アルキルエステル、安息香酸、安息香酸ナトリウム、ソルビン酸、ソルビン酸カリウム、フェノキシエタノール、サリチル酸、石炭酸、ソルビン酸、パラクロルメタクレゾール、ヘキサクロロフェン、塩化ベンザルコニウム、塩化クロルヘキシジン、感光素、フェノキシエタノール等が挙げられる。 The antiseptic antibacterial agent and antibacterial agent are not particularly limited. For example, paraoxybenzoic acid alkyl ester, benzoic acid, sodium benzoate, sorbic acid, potassium sorbate, phenoxyethanol, salicylic acid, coalic acid, sorbic acid, parachlorometacresol, hexachloro Examples include phen, benzalkonium chloride, chlorhexidine chloride, photosensitizer, and phenoxyethanol.
本発明を詳細に説明するために以下に実施例を挙げるが、本発明はこれらの例のみに限定されるものではない。特に断りのない限り、「%」は「質量%(重量%)」を、「部」は「質量部(重量部)」を、それぞれ意味する。
なお、各種物性等は以下のようにして評価した。
In order to describe the present invention in detail, examples are given below, but the present invention is not limited to these examples. Unless otherwise specified, “%” means “mass% (weight%)” and “part” means “part by mass (weight part)”.
Various physical properties were evaluated as follows.
1、粉体物性
(1)乾燥減量(%)
粉体2gを小数点以下3桁まで精秤し、120℃で2時間乾燥し、乾燥前後の重量差より算出した。
1. Physical properties of powder (1) Loss on drying (%)
2 g of the powder was precisely weighed to 3 digits after the decimal point, dried at 120 ° C. for 2 hours, and calculated from the weight difference before and after drying.
(2)強熱減量(%)
粉体2gを小数点以下3桁まで精秤し、500℃で1時間強熱し、強熱前後の重量差より算出した。
(2) Loss on ignition (%)
2 g of powder was precisely weighed to 3 digits after the decimal point, ignited at 500 ° C. for 1 hour, and calculated from the weight difference before and after ignition.
(3)比表面積(m2/g)
マウンテック製の全自動比表面積測定装置(Macsorb HM model−1220)により、脱気条件130℃、5分で測定した。
(3) Specific surface area (m 2 / g)
Measurement was performed at 130 ° C. for 5 minutes using a fully automatic specific surface area measuring device (Macsorb HM model-1220) manufactured by Mountec.
(4)IR比(A/B)
FT−IR(Nicolet iS 10:サーモフィッシャーサイエンティフィック社製)を用い、ATR法(ダイヤモンドプリズム)にて、2895〜2953cm−1での最大ピークの強度Aと、870〜886cm−1での最大ピークの強度Bとを測定した。
(4) IR ratio (A / B)
Largest in using, ATR method at (diamond prism), and the intensity A of the maximum peak at 2895~2953cm -1, 870~886cm -1: FT- IR ( Thermo Fisher made Scientific Nicolet iS 10) The peak intensity B was measured.
(5)平均粒子径(平均一次粒子径)
上述した方法に従って、平均一次粒子径を求めた。
(5) Average particle diameter (average primary particle diameter)
The average primary particle size was determined according to the method described above.
2、分散体物性
粉体50g、PEG−9ポリジメチルシロキシエチルジメチコン(信越化学工業社、KF−6028P)6g、デカメチルシクロベンタシロキサン44gをマヨネーズ瓶に配合し、φ0.5mmのジルコニアビーズ100gを入れ、ペイントシェーカーで60分間分散することにより、分散体を調製した。この分散体につき、以下のように粘度及び粒度(分布)を求めた。
2, 50 g of dispersion physical powder, 6 g of PEG-9 polydimethylsiloxyethyl dimethicone (Shin-Etsu Chemical Co., Ltd., KF-6028P), 44 g of decamethylcyclobentasiloxane were blended in a mayonnaise bottle, and 100 g of zirconia beads having a diameter of 0.5 mm were mixed. And a dispersion was prepared by dispersing for 60 minutes in a paint shaker. For this dispersion, the viscosity and particle size (distribution) were determined as follows.
(1)粘度(mPa・s)
B型粘度計(英弘精機社製、ローターNo.3、回転数12rpm)にて測定した。測定温度は25℃とした。
(1) Viscosity (mPa · s)
It was measured with a B-type viscometer (manufactured by Eiko Seiki Co., Ltd., rotor No. 3, rotation speed 12 rpm). The measurement temperature was 25 ° C.
(2)粒度(分布)
レーザー回折式粒度分布測定装置(LA−750:堀場製作所製)にて粒度分布を測定した。表中のD10、D50、D90はそれぞれ、体積基準での10%積算径、50%積算径(メディアン径とも称す)、90%積算径を意味する。
(2) Particle size (distribution)
The particle size distribution was measured with a laser diffraction particle size distribution analyzer (LA-750: manufactured by Horiba, Ltd.). D10, D50, and D90 in the table mean 10% integrated diameter, 50% integrated diameter (also referred to as median diameter), and 90% integrated diameter on a volume basis, respectively.
実施例1
酸化亜鉛(堺化学工業社製、FINEX−50、平均一次粒子径20nm)100gをミキサー(日本コークス工業製、Powder Lab)に入れ、ココイルグルタミン酸ナトリウム6gを溶解した水溶液50gを添加し、2000rpmで10分間混合した。その後、所定の回転数Xに変更し、撹拌したままタンク内を所定温度Yに上げ、更に真空ポンプで陰圧にして水等の揮発分を除去し粉体を得た。得られた粉体の物性を評価した。X、Yを表1に、評価結果を表2に示す。また、粉体を用いて上記のとおり分散体を調製し、物性を評価した。この結果も表2に示す。
Example 1
100 g of zinc oxide (manufactured by Sakai Chemical Industry Co., Ltd., FINEX-50, average primary particle size 20 nm) is put in a mixer (Powder Lab, manufactured by Nippon Coke Industries, Ltd.), 50 g of an aqueous solution in which 6 g of sodium cocoyl glutamate is dissolved is added, and 10 g at 2000 rpm. Mixed for minutes. Thereafter, the number of revolutions was changed to a predetermined number X, the inside of the tank was raised to a predetermined temperature Y while stirring, and further a negative pressure was removed with a vacuum pump to remove volatile components such as water to obtain a powder. The physical properties of the obtained powder were evaluated. X and Y are shown in Table 1, and the evaluation results are shown in Table 2. Moreover, the dispersion was prepared using the powder as described above, and the physical properties were evaluated. The results are also shown in Table 2.
実施例2、3、比較例1、2
X、Yを表1に示す通りに変更したこと以外は実施例1と同様にして各粉体を得た。粉体及び分散体の物性の評価結果を表2に示す。
Examples 2 and 3, Comparative Examples 1 and 2
Each powder was obtained in the same manner as in Example 1 except that X and Y were changed as shown in Table 1. The evaluation results of the physical properties of the powder and dispersion are shown in Table 2.
比較例3
酸化亜鉛(堺化学工業社製、FINEX−50、平均一次粒子径20nm)を、比較例3の粉体とした。この粉体及び分散体の物性の評価結果を表2に示す。
Comparative Example 3
Zinc oxide (FINEX-50, average primary particle size 20 nm, manufactured by Sakai Chemical Industry Co., Ltd.) was used as the powder of Comparative Example 3. The evaluation results of the physical properties of this powder and dispersion are shown in Table 2.
比較例4
酸化亜鉛(堺化学工業社製、FINEX−50、平均一次粒子径20nm)100gを純水500mlにリパルプし、30分間撹拌した。これを酸化亜鉛リパルプ液と称す。
またアルミン酸ナトリウム水溶液22mL(Al2O3濃度として244.1g/L、Al2O3換算で5.26g、Al(OH)3換算で8.0g添加)を水500mlで希釈した液(希釈液Aと称す)と、硫酸40mlを水500mlで希釈した液(希釈液Bと称す)との2つの希釈液を用意した。
酸化亜鉛リパルプ液に、希釈液Aを8ml/minで滴下しながら、同時に、希釈液Bを酸化亜鉛リパルプ液全体のpHが8〜9を維持する滴下速度で調整しながら室温で滴下した。希釈液Aの滴下が完了した時点で希釈液Bの滴下も終了し、30分間撹拌したまま熟成した。この反応液を濾過し、得られたケーキを電導度100μS/cm以下になるまで水洗し、130℃で12時間乾燥した。
こうして得た乾燥物を、酸化亜鉛の代わりに用いたこと以外は、実施例1と同様にして粉体(ココイルグルタミン酸ナトリウムによる表面処理物)を得た。この粉体及び分散体の物性の評価結果を表2に示す。
なお、この粉体の組成比は、酸化亜鉛/Al(OH)3/ココイルグルタミン酸ナトリウム=87/7/6(質量%)であった。
Comparative Example 4
100 g of zinc oxide (manufactured by Sakai Chemical Industry Co., Ltd., FINEX-50, average primary particle size 20 nm) was repulped into 500 ml of pure water and stirred for 30 minutes. This is called zinc oxide repulp liquid.
A solution obtained by diluting 22 mL of an aqueous sodium aluminate solution (added 244.1 g / L as Al 2 O 3 concentration, 5.26 g in terms of Al 2 O 3 and 8.0 g in terms of Al (OH) 3 ) with 500 ml of water (dilution) Two dilutions were prepared: liquid A) and a liquid obtained by diluting 40 ml of sulfuric acid with 500 ml of water (referred to as dilution B).
While the diluent A was added dropwise to the zinc oxide repulp solution at 8 ml / min, at the same time, the diluent B was added dropwise at room temperature while adjusting the dropping rate so that the pH of the entire zinc oxide repulp solution was maintained at 8-9. When the addition of the diluent A was completed, the addition of the diluent B was completed, and the mixture was aged with stirring for 30 minutes. The reaction solution was filtered, and the obtained cake was washed with water until the electric conductivity became 100 μS / cm or less, and dried at 130 ° C. for 12 hours.
A powder (surface-treated product with sodium cocoyl glutamate) was obtained in the same manner as in Example 1 except that the dried product thus obtained was used instead of zinc oxide. The evaluation results of the physical properties of this powder and dispersion are shown in Table 2.
The composition ratio of this powder was zinc oxide / Al (OH) 3 / sodium cocoyl glutamate = 87/7/6 (mass%).
表2中、※1を付した「強熱−乾燥」とは、強熱減量と乾燥減量との差である。これは当該粉体の表面処理量に該当する。 In Table 2, “Ignition-drying” marked with * 1 is the difference between loss on ignition and loss on drying. This corresponds to the surface treatment amount of the powder.
表2より、以下のことを確認した。
実施例1〜3で得た粉体は、表面がN−アシル化アミノ酸塩で処理されてなり、赤外分光法で測定した際に、IR比(A/B)が0.60〜1.20の範囲内であり、アルミニウム元素を含まないという本発明の構成からなる表面処理酸化亜鉛粉体に該当する。これに対し、比較例1、2で得た粉体は、IR比が1.20を超える例であるが、この場合、分散体に含まれる粒度が著しく大きくなることが分かる。一方、比較例3の粉体はIR比が0.60未満となる例であるが、このような粉体では溶媒に分散できなかった、すなわち分散体を仕上げることができなった。比較例4は、アルミニウム元素を含む粉体であるが、この場合、分散体は高粘度となり、しかも含まれる粉体の粒度が著しく大きくなった。従って、表面処理酸化亜鉛粉体が上述した本発明の構成からなることによって初めて、有機溶媒への分散性が向上され、しかも粒度が細かく低粘度の分散体を与えることができることが分かった。
更に、上記IR比に調整するためには、ミキサーで混合する際のミキサー羽根回転数による調整が必要であることも判明した。原因はわかっていないが、N−アシル化アミノ酸塩を安定的に処理するためには、処理方法により最適な条件が存在すると推定される。
From Table 2, the following was confirmed.
The powder obtained in Examples 1 to 3 has a surface treated with an N-acylated amino acid salt, and has an IR ratio (A / B) of 0.60 to 1 when measured by infrared spectroscopy. This corresponds to the surface-treated zinc oxide powder having the constitution of the present invention which is within the range of 20 and does not contain an aluminum element. In contrast, the powders obtained in Comparative Examples 1 and 2 are examples in which the IR ratio exceeds 1.20. In this case, it can be seen that the particle size contained in the dispersion is remarkably increased. On the other hand, the powder of Comparative Example 3 is an example having an IR ratio of less than 0.60. However, such a powder could not be dispersed in a solvent, that is, the dispersion could not be finished. Comparative Example 4 is a powder containing an aluminum element. In this case, the dispersion had a high viscosity, and the particle size of the contained powder was remarkably large. Therefore, it has been found that the dispersibility in an organic solvent is improved only when the surface-treated zinc oxide powder has the above-described configuration of the present invention, and furthermore, a dispersion having a fine particle size and a low viscosity can be provided.
Furthermore, in order to adjust to the IR ratio, it has been found that adjustment by the number of rotation of the mixer blades when mixing with a mixer is necessary. Although the cause is unknown, it is presumed that optimum conditions exist depending on the treatment method in order to stably treat the N-acylated amino acid salt.
Claims (6)
赤外分光法で測定した際に、2895〜2953cm−1での最大ピークの強度Aと、870〜886cm−1での最大ピークの強度Bとの比(A/B)が0.60〜1.20の範囲内であり、
アルミニウム元素を含まない
ことを特徴とする表面処理酸化亜鉛粉体。 The surface is treated with an N-acylated amino acid salt;
When measured by infrared spectroscopy, and strength A of the maximum peak at 2895~2953Cm -1, the ratio between the intensity B of the maximum peak at 870~886cm -1 (A / B) is 0.60 to 1 .20, and
A surface-treated zinc oxide powder characterized by not containing an aluminum element.
ことを特徴とする請求項1に記載の表面処理酸化亜鉛粉体。 2. The surface-treated zinc oxide powder according to claim 1, wherein an average primary particle size of the powder is 10 to 100 nm.
ことを特徴とする請求項1又は2に記載の表面処理酸化亜鉛粉体。 The surface-treated zinc oxide powder according to claim 1 or 2, wherein the N-acylated amino acid salt is cocoyl glutamate.
該分散体は、
粒度分布におけるD90が1000nm以下であり、
粉体濃度が40質量%以上である
ことを特徴とする分散体。 A dispersion comprising the surface-treated zinc oxide powder according to any one of claims 1 to 3 and an organic solvent,
The dispersion is
D90 in the particle size distribution is 1000 nm or less,
A dispersion having a powder concentration of 40% by mass or more.
ことを特徴とする請求項4に記載の分散体。 The dispersion according to claim 4, wherein the organic solvent contains silicone oil.
ことを特徴とする化粧料。
A cosmetic comprising the dispersion according to claim 4 or 5.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2017008420A JP6805839B2 (en) | 2017-01-20 | 2017-01-20 | Surface-treated zinc oxide powder and its applications |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2017008420A JP6805839B2 (en) | 2017-01-20 | 2017-01-20 | Surface-treated zinc oxide powder and its applications |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2018115098A true JP2018115098A (en) | 2018-07-26 |
JP6805839B2 JP6805839B2 (en) | 2020-12-23 |
Family
ID=62983850
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2017008420A Active JP6805839B2 (en) | 2017-01-20 | 2017-01-20 | Surface-treated zinc oxide powder and its applications |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP6805839B2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114869787A (en) * | 2022-06-08 | 2022-08-09 | 上海臻臣化妆品有限公司 | Surface-treated physical sun-screening agent and preparation method thereof |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH03240722A (en) * | 1990-02-15 | 1991-10-28 | Giyuuniyuu Setsuken Kiyoushinshiya Kk | Bathing agent |
JPH07277937A (en) * | 1994-04-01 | 1995-10-24 | Ajinomoto Co Inc | Powder for cosmetic and cosmetic containing the same |
JPH0859238A (en) * | 1994-08-24 | 1996-03-05 | Sumitomo Osaka Cement Co Ltd | Surface-treated zinc oxide powder |
JP2002362925A (en) * | 2001-06-06 | 2002-12-18 | Sumitomo Osaka Cement Co Ltd | Fine powder of surface coated zinc oxide and cosmetic material containing the dame |
JP2012171945A (en) * | 2011-02-24 | 2012-09-10 | Daito Kasei Kogyo Kk | Oily dispersion and cosmetic containing the same |
-
2017
- 2017-01-20 JP JP2017008420A patent/JP6805839B2/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH03240722A (en) * | 1990-02-15 | 1991-10-28 | Giyuuniyuu Setsuken Kiyoushinshiya Kk | Bathing agent |
JPH07277937A (en) * | 1994-04-01 | 1995-10-24 | Ajinomoto Co Inc | Powder for cosmetic and cosmetic containing the same |
JPH0859238A (en) * | 1994-08-24 | 1996-03-05 | Sumitomo Osaka Cement Co Ltd | Surface-treated zinc oxide powder |
JP2002362925A (en) * | 2001-06-06 | 2002-12-18 | Sumitomo Osaka Cement Co Ltd | Fine powder of surface coated zinc oxide and cosmetic material containing the dame |
JP2012171945A (en) * | 2011-02-24 | 2012-09-10 | Daito Kasei Kogyo Kk | Oily dispersion and cosmetic containing the same |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114869787A (en) * | 2022-06-08 | 2022-08-09 | 上海臻臣化妆品有限公司 | Surface-treated physical sun-screening agent and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
JP6805839B2 (en) | 2020-12-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4105971B2 (en) | Porous titanium oxide powder and method for producing the same | |
WO2013133412A1 (en) | Spherical zinc oxide particles of aggregated lamellar zinc oxide, method of preparing same, cosmetic and heat-dissipating filler | |
WO2016002751A1 (en) | Oil-in-water emulsion composition | |
KR20140046003A (en) | Dispersion | |
JP2011102291A (en) | Coated zinc oxide particles, water-based composition, and cosmetics | |
JP5967087B2 (en) | Method for producing round zinc oxide particles | |
TW200533377A (en) | Sun-block cosmetic | |
JP4060849B2 (en) | High concentration aqueous dispersion containing hydrophobic metal oxide fine particles and dispersion aid | |
JP7299874B2 (en) | Water-in-oil emulsified cosmetic | |
JPWO2016002752A1 (en) | Aqueous cosmetics | |
JP4683536B2 (en) | Sunscreen emulsified cosmetics | |
JP5794852B2 (en) | Titanium dioxide pigment for cosmetics and method for producing the same | |
JP2018115098A (en) | Surface treated zinc oxide powder and usage thereof | |
JP5907248B2 (en) | Zinc carbonate salt particles, zinc oxide particles, production method thereof, heat dissipating filler and cosmetic | |
WO2017026379A1 (en) | Flake-shaped hydrotalcite-type particle and application thereof | |
JP6733312B2 (en) | Liquid dispersion and its use | |
JP2023147613A (en) | Aqueous dispersion and cosmetic | |
JPWO2017203846A1 (en) | Liquid dispersion and use thereof | |
JP2014088351A (en) | Rare earth doped barium sulfate and cosmetics | |
JP6477173B2 (en) | Method for producing surface-coated zinc oxide particles | |
JP2018158914A (en) | Sebum-resistant powder and cosmetics containing the same | |
JP7358815B2 (en) | Liquid dispersion and its uses | |
JP5649839B2 (en) | Method for producing powder-containing oil-in-water emulsified cosmetic | |
JP2017178737A (en) | Manufacturing method of composite | |
JP2016108317A (en) | Solid composition blended with particulate inorganic powder surface-treated with hydrophobic organic surface treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20190829 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20200519 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20200602 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20200818 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20200924 |
|
C60 | Trial request (containing other claim documents, opposition documents) |
Free format text: JAPANESE INTERMEDIATE CODE: C60 Effective date: 20200924 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20201002 |
|
C21 | Notice of transfer of a case for reconsideration by examiners before appeal proceedings |
Free format text: JAPANESE INTERMEDIATE CODE: C21 Effective date: 20201006 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20201104 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20201117 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6805839 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |